Abstract
The idea of using low doses of gestagens as oral contraceptives (OC) was first explored by Rudel et al. (19). In recent years several reports have appeared describing the clinical results during this kind of treatment, for a summary see (9). Some authors (3, 18) seem to consider the major contraceptive effect of these drugs to be on the cervical mucus, making it hostile to spermatozoa while other investigators (6, 15, 22) believe that this can not be the only explanation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aakvaag, A. : Formation of steroid hormones in the porcine ovary in vitro. J. Endocr. 43:25 (1969).
Diczfalusy, E., Goebelsmann, U., Johannisson, E., Tillinger, K.-G., and Wide, L. : Pituitary and ovarian function in women on continuous low dose progestogens; effect of Chlormadinone acetate and Norethisterone. Acta Endocr. (Kbh.) 62:679 (1969).
Elstein, M.: Urinary hormone excretion patterns in Chlormadinone acetate treated patients and the associated cervical mucus changes. In Chlormadinone acetate, a new departure in oral contraception. Editors: G.A. Christie and M. Moore-Robinson. Excerpta med. (Amst.) 1969, p. 46.
Foss, G.L., Svendsen, E.K., Fotherby, K., and Richards, D.J.: Contraceptive action of continuous low doses of norgestrel. Brit. med. J. 4:489 (1968).
Geller, G. : In Chlormadinone acetate, a new departure in oral contraception. Editors: G.A. Christie and M. Moore-Robinson. Excerpta med. (Amst.) 1969, p. 108.
Gibor, Y., Cohen, M.R., and Scommegna, A.: Effect of continuous administration of small doses of Chlormadinone acetate on the cervical mucus and postcoital test. Fertil. Steril. 20:572, (1969).
Jaffe, R.B., and Midgley, A.B. Jr. : Effects of synthetic steroids on serum gonadotropins. In Progress in Conception Control 1968. Editor: D.L. Moyer, J.B. Lippincott, Philadelphia 1968, p. 13.
Johansson, E.D.B.: Progesterone levels in peripheral plasma during the luteal phase of the normal human menstrual cycle measured by a rapid competitive protein binding technique. Acta endocr. (Kbh.) 61:592 (1969).
Larsson-Cohn, U.: Contraceptive treatment with low doses of gestagens. Acta endocr. (Kbh.) Suppl. 144 (1970).
Larsson-Cohn, U., Johansson, E.D.B., Wide, L., and Gemzell, C.: Effects of continuous administration of 0.5 mg of Norethindrone on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone, pregnanediol and total oestrogens. Acta endocr. (Kbh.) 63:216 (1970).
Larsson-Cohn, U., Johansson, E.D.B., Wide, L., and Gemzell, C.: Effectsof continuous administration of 0.5 mg of Chlormadinone acetate on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. Acta endocr. (Kbh.) 63:705 (1970).
Larsson-Cohn, U., Johansson, E.D.B., and Gemzell, C.: Effects of continuous daily administration of 0.3 mg of Norethindrone on the plasma levels of progesterone and on the urinary excretion of pregnanediol and total oestrogens. Acta endocr. (Kbh.) 64:38 (1970).
Larsson-Cohn, U., Johansson, E.D.B., Wide, L., and Gemzell, C.: Effects of daily administration of a retrosteroid on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens. J. Obst. Gynec. Brit. Cwlth. in press.
Larsson-Cohn, U., Johansson, E.D.B., and Gemzell, C: Unpublished.
Martinez-Manautou, C., Giner-Velazquez, J., Aznar-Ramos, R., Lozano-Balderas, M., and Rudel, W.H.: Continuous administration of 0.5 mg of Chlormadinone acetate as a method of regulating fertility without inhibiting ovulation. In Proceedings of the eight international conference of the International Planned Parenthood Federation Santiago Chile 9–15 april 1967. Editors: R.K.B. Hankinson, R.L. Kleinman, P. Eckstein, and H. Romero. IPPF, London, 1967, p. 241.
Orr, A.H., and Elstein, M. : Luteinizing hormone levels in plasma and urine in women during normal menstrual cycles and in women taking combined contraceptives or Chlormadinone acetate. J. Endocr. 43:6l7 (1969).
∅stergaard, E., and Starup, J.: Occurrence and function of corpora lutea during different forms of oral contraception. Acta Endocr. (Kbh.) 57:386 (1968).
Roland, M.: Norgestrel-induced cervical barrier to sperm migration. J. Reprod. Fert. Suppl. 5:173 (1968).
Rudel, H.W., Martinez-Manautou, J., and Maqueo-Topete, M. : The role of progestogens in the hormonal control of fertility. Fertil. Steril. 16:158 (1965).
Stevens, V.C., and Vorys, N.: The regulation of pituitary function by sex steroids. Obst. Gyn. Survey 22:781 (1967).
Wright, S.W., Fotherby, K., and Fairweather, F.: Effect of daily small doses of norgestrel on ovarian function. J. Obstet. Gynaec. Brit. Cwlth. 77:65 (1970).
Zanartu, J., Rodriguez-Moore, G., Pupkin, M., Salas, O., and Guerrero, R.: Antifertility effect of continuous low-dosage oral progestogen therapy. Brit. med. J. 2:263 (1968).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1971 Plenum Press, New York
About this chapter
Cite this chapter
Larsson-Cohn, U. (1971). Influence of Low Doses of Gestagens on Some Pituitary-Ovarian Functions. In: Ingelman-Sundberg, A., Lunell, NO. (eds) Current Problems in Fertility. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-8651-7_27
Download citation
DOI: https://doi.org/10.1007/978-1-4615-8651-7_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-8653-1
Online ISBN: 978-1-4615-8651-7
eBook Packages: Springer Book Archive